Avalon BioVentures
SEC Form D filer · La Jolla
Avalon BioVentures filed an SEC Form D on November 12, 2026 for Avalon BioVentures II, LP, stating a total offering of $200M. The Avalon BioVentures filing is under SEC CIK 2160318 and lists an address in La Jolla, US. The filing names Avalon BioVentures II GP, LLC, Tighe Reardon and Jay Lichter as related persons. As of November 12, 2026, DryPowder has not verified the Avalon BioVentures thesis, check size or partners; this page shows only what the public filing says.
Updated · Source: SEC EDGAR
Filing facts FORM D
- Issuer on the filing
- Avalon BioVentures II, LP
- Firm
- Avalon BioVentures
- SEC CIK
- 2160318
- Accession number
- 0002160318-26-000001
- Form type
- D (new offering)
- Filed with the SEC
- Total offering amount
- $200M
- Address on filing
- La Jolla, US
- Fund type on the filing
- Venture Capital Fund
- Organized
- Delaware, 2026
- Exemptions claimed
- Rule 506(b); Investment Company Act 3(c)(7), qualified purchasers only
- Date of first sale
- Yet to occur at filing
- Amount sold at filing
- $0
- Partners
- Partner contacts appear once the profile is verified; the people the filing names are listed below.
People named on the filing FORM D
Related persons listed on the Form D: the executive officers, directors and promoters of the issuer or its general partner.
- Avalon BioVentures II GP, LLC · Director, General Partner of the Issuer
- Tighe Reardon · Director, Managing Director of the General Partner of the Issuer
- Jay Lichter · Director, Managing Director of the General Partner of the Issuer
- Sanford Madigan · Director, Managing Director of the General Partner of the Issuer
- Sergio Duron · Director, Managing Director of the General Partner of the Issuer
What this Form D tells a founder
A Form D is the notice a private fund files with the U.S. Securities and Exchange Commission when it sells interests under Regulation D. Venture firms file one for each new fund vehicle, usually within 15 days of the first sale to an investor, so a fresh filing is one of the earliest public signs that a firm is raising or has raised new capital.
The Avalon BioVentures filing on November 12, 2026 states a total offering of $200M. The stated amount is the target the fund may raise, not money already committed, and the filing does not name the companies the fund will back or the size of its checks.
DryPowder reads every venture Form D from SEC EDGAR, drops single-deal SPVs, and ties each filing to the firm behind it. Once DryPowder verifies the Avalon BioVentures website, stage, check size and partners, this page becomes a full profile.
Looking for funds writing checks now?
See every fund that filed a Form D recently, or get matched with verified seed and pre-seed funds.
Sources
- SEC EDGAR: Form D, Avalon BioVentures II, LP, filed
- Method: How DryPowder builds its data
Updated